The designation "daf-9" refers to distinct entities depending on the biological context:
In C. elegans:
DAF-9 is a cytochrome P450 enzyme (CYP450) critical for synthesizing dafachronic acid (DA), a steroid hormone that regulates larval development, lifespan, and germline proliferation via the nuclear receptor DAF-12 .
No commercial antibodies targeting C. elegans DAF-9 are documented in the provided sources.
In Human Biology:
Genetic Interactions:
Mechanistic Insights:
Available antibodies target human CD55/DAF, a glycoprotein regulating complement activation. These are unrelated to C. elegans DAF-9 but are included here due to nomenclature overlap:
No peer-reviewed studies or commercial products describe antibodies specific to C. elegans DAF-9.
The conflation likely arises from abbreviating "DAF" (decay-accelerating factor) in human biology with C. elegans gene names (e.g., daf-9).
For C. elegans studies: Use genetic tools (e.g., daf-9 mutants, RNAi) to investigate DAF-9 function.
For human CD55 studies: Employ validated antibodies (e.g., AF2009, #38730) with proper controls.